Xcellerex
Latest round
- Series C
Last raised
- Oct 2007
Total raised
- $42M
Investors
- 3
About Xcellerex
Xcellerex, Inc. develops biomolecule manufacturing technologies and platforms. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bioproducts, such as vaccines, yeast, and insulins; XDR single-use bioreactors, which are integrated systems for GMP clinical and commercial production.
Who invested in Xcellerex
3 investors across 2 rounds
See all investors in Xcellerex
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xcellerex
Who invested in Xcellerex?
Xcellerex has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xcellerex raised?
Xcellerex has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Xcellerex last raise money?
Xcellerex's most recent round on record is a Series C, in Oct 2007.
What does Xcellerex do?
Xcellerex is a pharmaceuticals company.
Where is Xcellerex headquartered?
Xcellerex is headquartered in Marlborough, US.
Which VCs invest in companies like Xcellerex?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Xcellerex's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Xcellerex? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.